Of particular concern was the proportion of undiagnosed patients; assuming current diagnostic protocols remain unchanged, most of the CKD population will not be eligible for treatment (unless therapeutic agents are prescribed for alternative reasons, such as angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the treatment of hypertension). The gene discussed is ACE; the disease is chronic kidney disease.